Facebook
Twitter
Telegram
Report an ErrorAkers Biosciences, Inc. Balance Sheet 2011-2024 | AKER
Annual Balance Sheet Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-517 K | -517 K | -182 K | -438 K | -72.7 K | -402 K | -456 K | 204 K | -633 K | -1.19 M |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
1.53 M | 1.53 M | 1.97 M | 1.77 M | 1.7 M | 1.67 M | 1.84 M | 1.95 M | 2.11 M | 715 K |
Total Liabilities |
1.53 M | 1.53 M | 1.97 M | 1.77 M | 1.7 M | 1.67 M | 1.84 M | 1.95 M | 2.11 M | 715 K |
Deferred Revenue |
- | - | - | 59.8 K | 59.8 K | - | 306 K | 639 K | 972 K | - |
Retained Earnings |
- | -120 M | -116 M | -103 M | -97.5 M | -94.2 M | -84.9 M | -81.7 M | -79.2 M | -76.7 M |
Total Assets |
10.9 M | 10.9 M | 7.81 M | 10.9 M | 5.09 M | 8.27 M | 16.7 M | 6.08 M | 6.42 M | 6.88 M |
All numbers in USD currency